Comparative Analysis of Pembrolizumab Dosing Schedules in the Adjuvant Treatment of Malignant Melanoma

Comparative Analysis of Pembrolizumab Dosing Schedules in the Adjuvant Treatment of Malignant Melanoma

Saved in:

Bibliographic Details
Main Authors:	Y. Ahmed, E. Finnegan, H. Ibrahim, D. Sabu
Format:	Article
Language:	English
Published:	Elsevier 2024-01-01
Series:	EJC Skin Cancer
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772611824001356
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Impact of Immune-Related Adverse Events on Melanoma Outcomes: A Comprehensive Analysis
by: Y. Ahmed, et al.
Published: (2024-01-01)

Real-World efficiency of pembrolizumab in metastatic melanoma patients following adjuvant anti-PD1 treatment
by: Michael Weichenthal, et al.
Published: (2024-12-01)

Melanoma Vaccines: Comparing Novel Adjuvant Treatments in High-Risk Patients
by: Joseph C. Broderick, et al.
Published: (2025-06-01)

Phase I study of pembrolizumab in combination with ibrutinib for the treatment of unresectable or metastatic melanoma
by: Yuan Yao, et al.
Published: (2025-02-01)

Adjuvant Therapy: Melanoma
by: Diwakar Davar, et al.
Published: (2011-01-01)

Lymphodepletion, tumor-infiltrating lymphocytes, and high versus low dose IL-2 followed by pembrolizumab in patients with metastatic melanoma
by: Merve Hasanov, et al.
Published: (2025-12-01)

Cytokine Release Syndrome Induced by Pembrolizumab for Metastatic Anal Melanoma
by: Erica Martel, et al.
Published: (2025-01-01)

Real‐World nivolumab dosing patterns and safety outcomes in patients receiving adjuvant therapy for melanoma
by: Wolfram Samlowski, et al.
Published: (2023-02-01)

Pembrolizumab and all-trans retinoic acid combination treatment of advanced melanoma: long-term survival update
by: Jessica S. W. Borgers, et al.
Published: (2025-06-01)

An update on adjuvant systemic therapies in melanoma
by: Evangeline Samuel, et al.
Published: (2019-11-01)

Treatment of recurrent mucosal melanoma of the oral cavity with topical imiquimod and pembrolizumab achieves complete histopathologic remission
by: Richard Carvajal, et al.
Published: (2021-10-01)

Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma
by: Ramses Sadek, et al.
Published: (2021-06-01)

Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial
by: Dirk Schadendorf, et al.
Published: (2024-03-01)

Clinical evaluation of HuDo-CSPG4 DNA electroporation as adjuvant treatment for canine oral malignant melanoma: comparison of two vaccination protocols
by: Mariateresa Camerino, et al.
Published: (2025-12-01)

Malignant Melanoma of the Conjunctiva
by: Grace R. Dizon, MD, et al.
Published: (2004-09-01)

Is There a Distinctive Molecular Identity for Sinonasal Malignant Mucosal Melanoma Compared to Cutaneous Melanoma?
by: M. Molina-García, et al.
Published: (2024-01-01)

A seven-year electroretinography follow-up of a patient with melanoma-associated retinopathy stabilized on pembrolizumab treatment
by: Raz Tshuva-Bitton, et al.
Published: (2025-06-01)

Sudden hearing loss in a melanoma patient on pembrolizumab: an etiology not to be omitted in the differential diagnosis
by: Matthew Zibelman, et al.
Published: (2017-08-01)

Malignant melanoma in childhood
by: T Salman, et al.
Published: (1986-10-01)

Molecular Dermatopathology in Malignant Melanoma
by: Marie-Annick Reginster, et al.
Published: (2012-01-01)

Multimodal therapy with surgery and adjuvant nivolumab for late-onset multiple liver metastases of choroidal malignant melanoma: a case report
by: Ryuta Muraki, et al.
Published: (2020-07-01)

Real-world experience with pembrolizumab toxicities in advanced melanoma patients: a single-center experience in the UK
by: Alfred CP So, et al.
Published: (2018-03-01)

Adjuvant Proton Beam Radiation Therapy for Sinonasal Mucosal Melanoma
by: Jamie S. K. Takayesu, et al.
Published: (2025-02-01)

Neo-adjuvant pembrolizumab in stage IV high-grade serous ovarian cancer: the phase II Neo-Pembro trial
by: S. L. Aronson, et al.
Published: (2025-04-01)

A case of long-term survival treated with three metastasectomies and two subsequent adjuvant nivolumab therapies for recurrent malignant melanoma of the esophagus
by: Keita Hanada, et al.
Published: (2022-11-01)

Tracking and Treating Malignant Melanoma Metastases
by: Gérald E. Piérard, et al.
Published: (2012-01-01)

Primary ovarian malignant melanoma
by: Kostov Miloš, et al.
Published: (2010-01-01)

Research progress and molecular mechanism of oridonin in the treatment of malignant melanoma
by: Tinghan Deng, et al.
Published: (2025-06-01)

Malignant melanoma of the skin. A preliminary report
by: H A Göksel
Published: (1964-07-01)

Meningioma with Metastatic Malignant Melanoma: An Unusual Coincidence
by: H. V. Savant, et al.
Published: (2017-05-01)

Methylphenidate Dosing Schedules
by: J Gordon Millichap
Published: (1996-11-01)

Uveal melanoma following Bruton's tyrosine inhibitor use for the treatment of hematologic malignancies
by: Tara Murty, et al.
Published: (2025-06-01)

Safety and efficacy of sintilimab versus pembrolizumab in the treatment of advanced or recurrent pediatric malignancies: a real-world study in China
by: Lei Mao, et al.
Published: (2025-06-01)

Effectiveness and safety of pembrolizumab, nivolumab, and atezolizumab as adjuvant therapy for high-risk muscle-invasive urothelial carcinoma: an indirect comparison
by: Wei Chen, et al.
Published: (2025-01-01)

Possibilities for Identifying the Malignant Vasculature of Choroidal Melanoma
by: E. V. Samkovich, et al.
Published: (2020-06-01)

Health-Care Delay in Malignant Melanoma: Various Pathways to Diagnosis and Treatment
by: Senada Hajdarevic, et al.
Published: (2014-01-01)

Malignant Melanoma Presenting as Spinal Cord and Pleural Lesions
by: Aysha Albastaki, et al.
Published: (2023-01-01)

Primary Malignant Melanoma of the Urinary Bladder
by: Jalal Eddine El Ammari, et al.
Published: (2011-01-01)

Malignant Melanoma Disguised as Biliary Obstruction
by: Jordan Wordekemper, et al.
Published: (2022-03-01)

Malignant gastrointestinal melanoma with an unknown primary
by: Krishna Mohan M.V.T, et al.
Published: (2009-01-01)